Who is sponsoring NCT02511821?

NCT02511821 is sponsored by City of Hope Medical Center.

What drugs are being tested in NCT02511821?

Interventions in NCT02511821: Computer-Assisted Intervention, Vivofit watch, Quality-of-Life Assessment, Questionnaire Administration.

What condition does NCT02511821 study?

NCT02511821 studies Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer, Stage IA Pancreatic Cancer, Stage IB Gastric Cancer, Stage IB Pancreatic Cancer, Stage II Adult Liver Cancer, Stage IIA Colorectal Cancer, Stage IIA Gastric Cancer, Stage IIA Pancreatic Cancer, Stage IIB Colorectal Cancer, Stage IIB Gastric Cancer, Stage IIB Pancreatic Cancer, Stage IIC Colorectal Cancer, Stage III Pancreatic Cancer, Stage IIIA Adult Liver Cancer, Stage IIIA Colorectal Cancer, Stage IIIA Gastric Cancer, Stage IIIB Adult Liver Cancer, Stage IIIB Colorectal Cancer, Stage IIIB Gastric Cancer, Stage IIIC Adult Liver Cancer, Stage IIIC Colorectal Cancer, Stage IIIC Gastric Cancer, Stage IV Gastric Cancer, Stage IVA Colorectal Cancer, Stage IVA Liver Cancer, Stage IVA Pancreatic Cancer, Stage IVB Colorectal Cancer, Stage IVB Liver Cancer, Stage IVB Pancreatic Cancer.

Is NCT02511821 still recruiting?

NCT02511821 is currently completed. Last updated 7 January 2021.

Last reviewed 2021-01-07 · How we verify

NCT02511821

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery

Completed NA Last updated 7 January 2021

What this trial tests

NA trial testing Computer-Assisted Intervention in Stage I Adult Liver Cancer in 22 participants. Completed in 31 July 2016.

Timeline

22 July 2015

Primary endpoint
31 July 2016

31 July 2016

Quick facts

Lead sponsor	City of Hope Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	22
Start date	22 July 2015
Primary completion	31 July 2016
Estimated completion	31 July 2016
Sites	1 location across United States

Drugs / interventions tested

Computer-Assisted Intervention
Vivofit watch
Quality-of-Life Assessment
Questionnaire Administration

Conditions studied

Stage I Adult Liver Cancer — all drugs for Stage I Adult Liver Cancer →
Stage I Colorectal Cancer — all drugs for Stage I Colorectal Cancer →
Stage IA Gastric Cancer — all drugs for Stage IA Gastric Cancer →
Stage IA Pancreatic Cancer — all drugs for Stage IA Pancreatic Cancer →

Sponsor

City of Hope Medical Center

Who can join

21 and older, any sex, with Stage I Adult Liver Cancer or Stage I Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot clinical trial studies an electronic monitoring device of patient-reported outcomes (PROs) and function in improving patient-centered care in patients with gastrointestinal cancer undergoing surgery. Electronic monitoring is a technology-based way of asking patients about the quality of life, symptoms, and activity using online surveys and an activity tracking watch may make it easier for patients to tell their doctors and nurses about any issues before and after surgery. Electronic systems of assessing PROs may increase the depth and accuracy of available clinical data, save administrative time, prompt early intervention that improves the patient experience, foster patient-provider communication, improve patient safety, and enhance the consistency of data collection across multiple sites.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Wireless Monitoring Program of Patient-Centered Outcomes and Recovery Before and After Major Abdominal Cancer Surgery.
Sun V, Dumitra S, Ruel N, Lee B, et al · · 2017 · cited 75× · PMID 28593266 · DOI 10.1001/jamasurg.2017.1519

Verify or expand the search:

Other trials of Computer-Assisted Intervention

Trials testing the same drug.

NCT07206589 — Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial · NA · not yet recruiting
NCT05018208 — Remote Monitoring in Cancer Care: A Platform Study · completed
NCT04358276 — Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Provide · NA · active not recruiting
NCT02378012 — iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant · NA · terminated
NCT03457480 — Text Messages in Preventing Tobacco Use in Young Adults · NA · completed

Other City of Hope Medical Center trials

Trials by the same sponsor.

NCT07365306 — Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant · Phase 2 · not yet recruiting
NCT07218692 — RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · Phase 2 · not yet recruiting
NCT07363408 — Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment · Phase 1 · not yet recruiting
NCT07226102 — Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic o · NA · withdrawn
NCT07225855 — Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Can · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02511821 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by City of Hope Medical Center
Last refreshed: 7 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02511821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing